International Society for the Study of Vulvovaginal Disease

EIN: 237244966 501(c)(3)

Waxhaw, NC

Total Revenue
$474,522
Total Expenses
$486,144
Total Assets
$839,573
Net Assets
$838,581
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
1971
Legal Domicile
NC
Principal Officer
Debbie Roepe
Phone
7047093511
Tax Period
2023-01-01 to 2023-12-31

International Society for the Study of Vulvovaginal Disease, founded in 1971, is a small nonprofit that reported $475K in total revenue in fiscal year 2023. Revenue decreased 18% compared to the prior year.

Mission

To promote international communication and education among gynecologists, pathologists, dermatologists, and and other healthcare providers, and to establish agreement on terminology and definitions of vulvovaginal diseases. To promote clinical investigation, basic research, and dissemination of knowledge in this field.

Program Service Accomplishments

Program 1
Expenses: $437,530 Revenue: $334,045

The ISSVD Continuing Medical Education program supports the mission of the ISSVD to advance womens health through life-long education of its members.Goals1.To promote clinical investigation, basic...

Read more

The ISSVD Continuing Medical Education program supports the mission of the ISSVD to advance womens health through life-long education of its members.Goals1.To promote clinical investigation, basic research, and dissemination of knowledge in this field.2.To promote international communication among gynecologists, pathologists, dermatologists, and related disciplines, and to establish international agreement on terminology and definitions of vulvovaginal diseases.3.To facilitate improvement in womens health care outcomes with a diverse, evidence-based and comprehensive selection of educational opportunities.4.To support life-long learning through a continuing medical education program developed and directed to address clinical practice gaps and other learning needs identified nationally, locally, or individually.5.The expected results of the CME program is that learners will be able to: -gain and apply knowledge about important womens health issues -use the tools and skills provided during the CME activity to make a meaningful, positive impact in the health of women and -make a commitment to change behavior or practice as a result of participating in the CME activityVulvovaginal disease is not taught formally in medical schools or any other educational program. Therefore there are many practice gaps in the diagnosis and management of women suffering from the various vulvovaginal diseases that affect 8-15% of women at some point in their life. Research supports that 8-15% of women will suffer from vulvar pain lasting at least 6 months sometime in their lifetime. Many primary care providers and womens health practitioners incorrectly diagnose vulvar pain disorders.Many healthcare professionals demonstrate a lack of awareness about the various options for diagnosing and treating the varied symptoms that affect their female patients. Differences among terminology between countries increases the likelihood of misdiagnosis and treatment. Through the educational programs offered by ISSVD, we aim to increase the following: Knowledge: being aware of what to doCompetence: being able to apply knowledge, skills, and judgment in practice (knowing how to do something)Performance: having the ability to implement the strategy or skill (what one actually does)And to: -Give participants new abilities/strategies (change competence).-Help participants modify their practice (change performance).-Help improve patient outcomes.After identifying the practice gaps and educational needs, we will identify what we want the learner to be able to accomplish after the activity and produce learning objectives.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $115,933
Program Service Revenue $334,045
Investment Income $3,138
Other Revenue $21,406
TOTAL REVENUE $474,522

Expense Breakdown

Grants Paid $0
Salaries & Benefits $164,192
Fundraising Expenses $0
Program Expenses $437,530
Other Expenses $321,952
TOTAL EXPENSES $486,144

Year-over-Year Comparison

2023 2022 Change
Revenue $474,522 $578,378 -0.2%
Expenses $486,144 $567,905 -0.1%
Net Income $-11,622 $10,473 -2.1%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
9
Independent Members
9
Employees
2
Volunteers
10

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
4
$122,893
Total Directors
9
$0
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
Debbie Roepe Executive Dir. 60.00
Officer
$113,683 $9,210 $122,893
Tanja Bohl MD President 1.00
Officer Director
$0 $0 $0
Colleen Stockdale MD MS Past President 1.00
Director
$0 $0 $0
Debra Heller MD President Elect 1.00
Director
$0 $0 $0
Pedro Baptista Secretary Gener 10.00
Officer Director
$0 $0 $0
Jill Allbritton Board member 1.00
Director
$0 $0 $0
Mitchell Berger MD Treasurer 1.00
Officer Director
$0 $0 $0
Jason Reutter Board member 1.00
Director
$0 $0 $0
Aruna Venkatesan Board member 1.00
Director
$0 $0 $0
Eleonora Preti Board member 1.00
Director
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 No data No data No data No data
2023 $474,522 $486,144 $839,573 $-11,622
2022 $578,378 $567,905 $852,236 $10,473
2021 $319,571 $371,998 $843,170 $-52,427
2020 $426,701 $286,074 $892,324 $140,627
2019 $617,569 $554,105 $769,683 $63,464
2018 $498,591 $489,707 $688,116 $8,884
Explore More Nonprofits
Top 100 Nonprofits in North Carolina Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare International Society for the Study of Vulvovaginal Disease with other nonprofits in North Carolina and across the country.